"HEK293 Cells" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cell line generated from human embryonic kidney cells that were transformed with human adenovirus type 5.
| Descriptor ID |
D057809
|
| MeSH Number(s) |
A11.251.210.172.750 A11.436.334
|
| Concept/Terms |
HEK293 Cells- HEK293 Cells
- Cell, HEK293
- Cells, HEK293
- HEK293 Cell
- 293T Cells
- 293T Cell
- Cell, 293T
- Cells, 293T
- HEK 293 Cells
- 293 Cell, HEK
- 293 Cells, HEK
- Cell, HEK 293
- Cells, HEK 293
- HEK 293 Cell
- Human Kidney Cell Line 293
- Human Embryonic Kidney Cell Line 293
- HEK 293 Cell Line
|
Below are MeSH descriptors whose meaning is more general than "HEK293 Cells".
Below are MeSH descriptors whose meaning is more specific than "HEK293 Cells".
This graph shows the total number of publications written about "HEK293 Cells" by people in this website by year, and whether "HEK293 Cells" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 0 | 10 | 10 |
| 2011 | 0 | 25 | 25 |
| 2012 | 0 | 30 | 30 |
| 2013 | 0 | 39 | 39 |
| 2014 | 0 | 41 | 41 |
| 2015 | 0 | 35 | 35 |
| 2016 | 0 | 37 | 37 |
| 2017 | 0 | 48 | 48 |
| 2018 | 0 | 52 | 52 |
| 2019 | 0 | 44 | 44 |
| 2020 | 0 | 39 | 39 |
| 2021 | 0 | 39 | 39 |
| 2022 | 0 | 6 | 6 |
| 2023 | 0 | 3 | 3 |
| 2024 | 0 | 12 | 12 |
| 2025 | 0 | 9 | 9 |
To return to the timeline,
click here.
Below are the most recent publications written about "HEK293 Cells" by people in Profiles.
-
a2d-2 regulates synaptic GluK1 kainate receptors in Purkinje cells and motor coordination. Brain. 2025 Apr 03; 148(4):1271-1285.
-
Androgen receptor ubiquitination links KCTD13 to genitourinary tract defects. FASEB J. 2025 Feb 28; 39(4):e70406.
-
PSKH1 kinase activity is differentially modulated via allosteric binding of Ca2+ sensor proteins. Proc Natl Acad Sci U S A. 2025 Feb 25; 122(8):e2420961122.
-
Combined clinical, structural and cellular studies discriminate pathogenic and benign TRPV4 variants. Brain. 2025 Feb 03; 148(2):564-579.
-
Characterization of Rationally Designed CRISPR/Cas9-Based DNA Methyltransferases with Distinct Methyltransferase and Gene Silencing Activities in Human Cell Lines and Primary Human T Cells. ACS Synth Biol. 2025 Feb 21; 14(2):384-397.
-
DNA-binding affinity and specificity determine the phenotypic diversity in BCL11B-related disorders. Am J Hum Genet. 2025 Feb 06; 112(2):394-413.
-
Axin-binding domain of glycogen synthase kinase 3? facilitates functional interactions with voltage-gated Na+?channel Nav1.6. J Biol Chem. 2025 Feb; 301(2):108162.
-
Nav1.2 channel mutations preventing fast inactivation lead to SCN2A encephalopathy. Brain. 2025 Jan 07; 148(1):212-226.
-
Enhanced motivated behavior mediated by pharmacological targeting of the FGF14/Nav1.6?complex in nucleus accumbens neurons. Nat Commun. 2025 Jan 02; 16(1):110.
-
ClC-Kb pore mutation disrupts glycosylation and triggers distal tubular remodeling. JCI Insight. 2024 Nov 22; 9(22).